Patents by Inventor Raphaëlle Bourdet-Sicard

Raphaëlle Bourdet-Sicard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CEREAL-BASED COMPOSITIONS WITH A MIX OF GALACTO-OLIGOSACCHARIDES/FRUCTO- OLIGOSACCHARIDES AND USES THEREOF FOR IMPROVING IRON ABSORPTION
    Publication number: 20240238319
    Abstract: The present invention is in the field of cereal-based compositions for preventing and/or treating iron deficiency, in particular intended for infants, young children, women of reproductive age including pregnant or lactating women, and elderly. The invention relates to a composition comprising at least a mixture of galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), cereal and iron and uses thereof.
    Type: Application
    Filed: May 27, 2021
    Publication date: July 18, 2024
    Inventors: Raphaëlle BOURDET-SICARD, Morgane BERGEONNEAU, Michaël Bruce ZIMMERMANN
  • LACTOCOCCUS LACTIS FOR USE IN PREVENTING OR TREATING MINERAL DEFICIENCY
    Publication number: 20230200422
    Abstract: The present invention relates to the use of Lactococcus lactis suitable for preventing or treating mineral deficiency or insufficiency by increasing the bioavailability of phytate bound minerals. The present invention provides novel strains, compositions comprising said strains and methods for the preparation of such compositions.
    Type: Application
    Filed: May 25, 2020
    Publication date: June 29, 2023
    Inventors: Audrey BONIFACE-GUIRAUD, Jean-Michel FAURIE, Raphaëlle BOURDET-SICARD
  • with anti-oxidant action
    Patent number: 9056123
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: June 16, 2015
    Assignee: Compagnie Gervais Danone
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaëlle Bourdet-Sicard
  • Lactobacilli with Anti-Oxidant Action
    Publication number: 20130171117
    Abstract: The present invention relates to specific Lactobacillus strains with an anti-oxidant effect.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 4, 2013
    Inventors: Gianfranco Grompone, Marie-Christine Degivry, Sophie Legrain-Raspaud, Isabelle Chambaud, Raphaëlle Bourdet-Sicard
  • Use of for increasing the protection provided by the influenza vaccine
    Patent number: 8349315
    Abstract: The invention relates to the use of Lactobacillus casei in orally administrable compositions for increasing protection against influenza after the influenza vaccine, by potentiating the humoral response generated by said vaccine.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: January 8, 2013
    Assignee: Compagnie Gervais Danone
    Inventors: Sandrine Samson-Villeger, Raphaëlle Bourdet-Sicard
  • Use of a fermented milk containing for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
    Patent number: 8309074
    Abstract: The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, Lactobacillus casei CNCM I-1518, which is present in Actimel®, for alleviating the symptoms of a delayed-type hypersensitivity reaction.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: November 13, 2012
    Assignee: Compagnie Gervais Danone
    Inventors: Jean François Nicolas, Catherine Goujon, Raphaëlle Bourdet-Sicard, Nathalie Rolf-Pedersen
  • Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation
    Publication number: 20100284973
    Abstract: The present invention pertains to the field of prevention and treatment of chronic or acute diseases involving mast cells, such as allergy and some autoimmune diseases. More precisely, the present invention concerns the use of probiotics containing a L. casei strain and/or a B. breve strain for inhibiting mast cell activation. The present invention relates also to screening processes for identifying bacterial strains which can be used for preparing said probiotics.
    Type: Application
    Filed: December 1, 2008
    Publication date: November 11, 2010
    Inventors: Cécile Schiffer-Mannioui, Mare Daëron, Sandrine Samson, Raphaëlle Bourdet-Sicard